Work

The year in cardiovascular medicine 2024: the top 10 papers in thrombosis and antithrombotic treatment

Year: 2025

Type: article

Abstract: Ten 2024 papers on thrombosis and antithrombotic therapy with potential impact on clinical practice. Some confirm current practice, others induce moderation or focus on new developments. ACS, acute coronary syndrome; AF, atrial fibrillation; CCS, chronic coronary syndrome; DAPT, dual antiplatelet therapy; DOAC, direct oral anticoagulant; F, factor; HBR, high bleeding risk; IPDM, individual patient–data meta-analysis; OAC, oral anticoagulant; PE, pulmonary embolism; PCI, percutaneous coronary intervention; TAVI, transcatheter aortic valve implantation; VKA, Vitamin K antagonist.

Source: European Heart Journal

DOI: 10.1093/eurheartj/ehaf126

Authors: Felicita Andreotti, Jurriën M Ten Berg, Michelle L O’Donoghue

Institutions: Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic, Istituti di Ricovero e Cura a Carattere Scientifico, Maastricht University Medical Centre, St. Antonius Ziekenhuis, Brigham and Women's Hospital, Thrombolysis in Myocardial Infarction Study Group

Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4408452714

FWCI: 0.646

Cites: 19

Cited by: 1

Related to: 10